• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR FEMOSTOP II PLUS; CLAMP, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR FEMOSTOP II PLUS; CLAMP, VASCULAR Back to Search Results
Catalog Number UNK FEMOSTOP II PLUS
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Hematoma (1884); Nerve Damage (1979); Pain (1994); Swelling/ Edema (4577)
Event Date 11/18/2020
Event Type  Injury  
Event Description
It was reported that after a cardiac catheterization procedure done on (b)(6) 2020, manual compression was applied to the right groin to achieve hemostasis.About 5 hours after the procedure, a knot/lump was noted in the groin and some bleeding was noted.A femostop device was placed at about 6:00 pm.The whole night the patient experienced tightness and was unable to get up to use the bathroom.By 8:00 am, the femostop device had been on the patient for 14 hours without it being monitored.Per the physician¿s orders, the femostop was removed as there was no bleeding.The patient had severe bruising and swelling all around the groin.He could not feel the sensation or urge to urinate, and he had to be catheterized.An ultrasound was done on the bladder.On (b)(6) 2020, the patient was unable to urinate, and the groin area was black.The patient returned to hospital and was sent to the emergency room to get catheterized.Now two years later, the patient has had urinary problems (no control of bladder) and numbness all the way down right leg.No additional information was provided.
 
Manufacturer Narrative
D4- the udi number is not known as the catalogue number was not provided.H6- device code 2017/failure to follow steps / instructions.Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record and complaint history of the reported device could not be conducted because the part and lot number were not provided.Reportedly, the femostop device had been on the patient for 14 hours without it being monitored.It should be noted that the warning in the femostop ii plus instructions for use (ifu) states: do not leave the system on the patient for inappropriately long compressions, as tissue damage may occur.A brief interruption at least every three hours of pressure is recommended during long compression periods.Inappropriately long compression and/or immobilization may increase the risk for thrombosis or embolization which could lead to patient injury or death.In this case it is possible the ifu deviation contributed to the reported patient effects.The investigation determined the reported ifu violation was due to operator error and the patient effects and treatment appear to be related to circumstances of the procedure.The reported patient effects of pain and hematoma are listed in the femostop ii plus ifu as known adverse events associated with use of suture mediated closure devices.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.B1: adverse event/product problem - product problem removed.B2: outcomes attributed to ae - disability or permanent damage added.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FEMOSTOP II PLUS
Type of Device
CLAMP, VASCULAR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT MEDICAL REG#3009600098
4 robbins rd
westford MA 01886
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16887794
MDR Text Key314757437
Report Number2024168-2023-04877
Device Sequence Number1
Product Code DXC
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K982182
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 08/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/08/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK FEMOSTOP II PLUS
Was Device Available for Evaluation? No
Date Manufacturer Received07/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability; Hospitalization;
Patient Age68 YR
Patient SexMale
Patient Weight100 KG
-
-